Efficacy and safety of durvalumab rechallenge in advanced hepatocellular carcinoma patients refractory to prior anti-PD-1 therapy

Kuan Chang Lai, Yen Hao Chen, Yi‑Ping Hung, Nai Jung Chiang, Ming‑Huang Chen, San Chi Chen*

*此作品的通信作者

研究成果: 期刊稿件 › 文章 › 同行評審

指紋

深入研究「Efficacy and safety of durvalumab rechallenge in advanced hepatocellular carcinoma patients refractory to prior anti-PD-1 therapy」主題。共同形成了獨特的指紋。

Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science